Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

News > All

Total search results: 6939 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 63 64 65 ... 68 69 70  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Qiagen N.V.. (5/16/19). "Press Release: Qiagen and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions". Hilden, Germantown, MD & Plymouth Meeting, PA. 2019-05-16
Roche. (5/16/19). "Press Release: Roche’s Personalised Medicine Entrectinib Shrank Tumours Harbouring NTRK, ROS1 or ALK Gene Fusions in Children and Adolescents". Basel. 2019-05-16
Roche. (5/16/19). "Press Release: Roche Announces FDA Approval for Venclexta plus Gazyva for People with Previously Untreated Chronic Lymphocytic Leukaemia". Basel. 2019-05-16
MorphoSys AG. (5/16/19). "Press Release: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, Has Been MMet, Confirming Previously Published Activity". Planegg. 2019-05-16
Bluebird Bio, Inc.. (5/16/19). "Press Release: Bluebird Bio to Present New Data from Clinical Studies of LentiGlobin Gene Therapy for Transfusion-Dependent ß-thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Con 2019-05-16
Genovis AB. (5/16/19). "Press Release: Genovis Signs Distribution Agreement with Fujifilm Wako Pure Chemical for Japan, Taiwan and Singapore Markets". 2019-05-16
Alveron Pharma B.V.. (5/16/19). "Press Release: Alveron Pharma Closes Series a Round to Advance a Cyclodextrin Based Procoagulant Medicine into the Clinic". Nijmegen. 2019-05-16
Symphogen A/S. (5/16/19). "Press Release: Symphogen Publishes Discovery and Pre-clinical Data on First Chicken-derived Antibody to Enter Human Clinical Trials. Sym021 a Novel Anti-PD1 Compound Currently in Phase 1 Clinical Trials". Copenhagen. 2019-05-16
Codexis, Inc.. (5/15/19). "Press Release: Codexis Announces CodeEvolver Technology Transfer and License Agreement with Global Pharmaceutical Leader". Redwood City, CA. 2019-05-15
Illumina, Inc.. (5/15/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Denmark". San Diego, CA. 2019-05-15
High-Tech Gründerfonds Management GmbH. (5/15/19). "Press Release: Navan Closes Seed Funding Round – Investors include Amgen Ventures, HTGF and Hemi Ventures". 2019-05-15
ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. 2019-05-15
Symphogen A/S. (5/15/19). "Press Release: Symphogen Announces New Capital Raise and Explores Strategic Options". 2019-05-15
Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg. 2019-05-15
Adaptimmune Therapeutics plc. (5/15/19). "Press Release: Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products". Philadeliphia, PA & Oxfordshire. 2019-05-15
Roche. (5/15/19). "Press Release: Roche Reports Very Strong Performance in the First Half of 2019 – Outlook Raised". Philadeliphia, PA & Oxfordshire. 2019-05-15
MCG Motion Capture GmbH. (5/15/19). "Press Release: MCG Motion Capture GmbH Founded by Seasoned Medtech and Digital Health Entrepreneurs". Heidelberg & Potsdam. 2019-05-15
Phathom Pharmaceuticals, Inc.. (5/15/19). "Press Release: Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals". Cambridge, MA & Menlo Park, CA. 2019-05-15
MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY. 2019-05-14
MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-05-14
Debiopharm International SA. (5/14/19). "Press Release: Debiopharm Awarded $2.1 Million from CARB-X in the Fight against a Highly Resistant Nosocomial-pneumonia Causing Superbug". Lausanne. 2019-05-14
SensID GmbH. (5/14/19). "Press Release: SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards". Göteborg & Rostock. 2019-05-14
Mobidiag Oy. (5/14/19). "Press Release: Investment Plan for Europe – Mobidiag Secures EUR 25 million from EIB". 2019-05-14
Roche. (5/14/19). "Press Release: New Roche Test Aids Clinicians in Accelerating Tuberculosis Diagnosis and Treatment by Detecting Antimicrobial Resistance within the World’s Leading Cause of Infectious Disease Deaths". Basel. 2019-05-14
Sekisui Diagnostics, LLC. (5/14/19). "Press Release: Sekisui Diagnostics Invests $1.9 Million in Microbial Biopharma CDMO Business". Lexington, MA. 2019-05-14
Medigene AG. (5/14/19). "Press Release: Medigene Reports Financial & Business Results for the First Three Months of 2019". Martinsried. 2019-05-14
F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge. 2019-05-14
Evotec SE. (5/14/19). "Press Release: Evotec SE Reports First Quarter 2019 Results and Provides Corporate Update". Hamburg. 2019-05-14
Icometrix. (5/14/19). "Press Release: Brain Imaging AI Leader Icometrix Raises $18 Million in New Funding". Leuven, Geenva & Boston, MA. 2019-05-14
Tissium S.A.. (5/14/19). "Press Release: Gecko Biomedical Rebrands as Tissium. Tissium Branding Reflects Broader Focus on Tissue Reconstruction". Paris. 2019-05-14
Centogene AG. (5/13/19). "Press Release: Centogene Launches Two Year Global Parkinson's Disease Study". Cambridge, MA & Rostock. 2019-05-13
TreeFrog Therapeutics SAS. (5/13/19). "Press Release: TreeFrog Therapeutics Raises over €7M ($7.8M) in Series A Financing Round 6 Months after Incorporation". Bordeaux. 2019-05-13
Philogen S.p.A.. (5/13/19). "Press Release: Philogen Announces €62 Million Financing Round". Siena. 2019-05-13
Bruker Corporation. (5/13/19). "Press Release: Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications". Montréal. 2019-05-13
ElevateBio, LLC. (5/13/19). "Press Release: ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies". Cambridge, MA. 2019-05-13
Bruker Corporation. (5/10/19). "Press Release: Bruker Announces New $300 Million Share Repurchase Authorization and Quarterly Dividend". Billerica, MA. 2019-05-10
MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY. 2019-05-10
Forschungszentrum Jülich. (5/10/19). "Press Release: Alzheimer Therapy from Jülich Passes another Important Test. Drug Candidate PRI-002 Has Successfully Completed Phase I of Clinical Research". Jülich & Vienna. 2019-05-10
Qiagen N.V.. (5/10/19). "Press Release: Disclosure According to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase". 2019-05-10
Roche Diagnostics GmbH. (5/10/19). "Pressemitteilung: Neuer Geschäftsführer Personal bei der Roche Diagnostics GmbH. Mit Wirkung zum 1. Juni 2019 folgt Andreas Schmitz auf Edgar Vieth". Mannheim & Penzberg. 2019-05-10
Uniqure N.V.. (5/10/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. 2019-05-10
Centogene AG. (5/9/19). "Press Release: Centogene Expands Executive Leadership Team". Cambridge, MA & Rostock. 2019-05-09
Polyphor Ltd.. (5/9/19). "Press Release: Polyphor Temporarily Halts Enrollment in the Phase III Studies of Murepavadin for the Treatment of Patients with Nosocomial Pneumonia". Allschwil. 2019-05-09
Medigene AG. (5/9/19). "Press Release: Bluebird Presents Preclinical Data of First TCR Candidate from Medigene Collaboration. Start Clinical Development 2020". Martinsried. 2019-05-09
L.E.K. Consulting. (5/9/19). "Press Release: L.E.K.’s Fabio LaMola to Speak at HealthInvestor Asia Summit 2019". Singapore. 2019-05-09
Pfizer Inc.. (5/8/19). "Press Release: Pfizer Acquires Clinical-Stage Biotech Therachon". New York, NY & Basel. 2019-05-08
BioNTech SE. (5/8/19). "Press Release: BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio". Mainz. 2019-05-08
Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna. 2019-05-08
Grünenthal GmbH. (5/8/19). "Press Release: Grünenthal to Strengthen Core Competencies in R&D". Aachen. 2019-05-08
OMass Therapeutics Ltd.. (5/8/19). "Press Release: OMass Therapeutics Appoints Rosamond Deegan as Chief Executive Officer". Oxford. 2019-05-08
Curadev Pvt. Ltd.. (5/8/19). "Press Release: Curadev Announces Licensing Agreement With Takeda for Novel STING Agonist". London. 2019-05-08
Promethera Biosciences S.A.. (5/7/19). "Press Release: Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing". Mont-Saint-Guibert & Tokyo. 2019-05-07
Confo Therapeutics N.V.. (5/7/19). "Press Release: Confo Therapeutics Raises €30 Million in Series A Financing". Ghent. 2019-05-07
Pfizer Inc.. (5/7/19). "Press Release: European Commission Approves Lorviqua (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer". 2019-05-07
Immunocore Ltd.. (5/7/19). "Press Release: Immunocore Appoints Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer". Oxfordshire, Pennsylvania & Maryland. 2019-05-07
High-Tech Gründerfonds Management GmbH. (5/7/19). "Press Release: Drug Discovery Technology Start-up DyNAbind Secures Seed Financing". 2019-05-07
MorphoSys AG. (5/7/19). "Press Release: MorphoSys AG Reports First Quarter 2019 Results". Planegg. 2019-05-07
Sanofi S.A.. (5/7/19). "Press Release: Dupixent (dupilumab) Approved for Severe Asthma by European Commission". Paris & Tarrytown, NY. 2019-05-07
Symrise AG. (5/6/19). "Press Release: Symrise Acquires Italian Biotech Company Cutech. Adds Competitive Edge in Bio-analytical Methods – Expands R&D Capacities for the Efficacy Testing of Cosmetic Ingredients". 2019-05-06
H. Lundbeck A/S. (5/6/19). "Press Release: Lundbeck to Acquire Abide Therapeutics, Adding a Unique Discovery Platform and a Lead Compound in an Exploratory Phase IIa Program for Tourette’s". Valby & San Diego, CA. 2019-05-06
Erytech Pharma. (5/6/19). "Press Release: Erytech Proposes the Appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors". Lyon. 2019-05-06
Merck KGaA. (5/6/19). "Press Release: Merck Signs Definitive Agreement to Acquire Intermolecular for $1.20 per Share in an All Cash Transaction". Darmstadt. 2019-05-06
Pharmaseal International Ltd.. (5/6/19). "Press Release: Pharmaseal Closes £1m Funding Round for Nkew CTMS Software". 2019-05-06
SGS S.A.. (5/3/19). "Press Release: SGS Acquires Chemical Solutions Ltd., USA". 2019-05-03
Devicare S.L.. (5/3/19). "Press Release: Devicare Launches Lit-Control in the US with Diem Labs". 2019-05-03
Amal Therapeutics S.A.. (5/2/19). "Press Release: Amal Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091". Geneva. 2019-05-02
Fluidigm Corporation. (5/2/19). "Press Release: Fluidigm Announces First Quarter 2019 Financial Results". South San Francisco, CA. 2019-05-02
High-Tech Gründerfonds Management GmbH. (5/2/19). "Press Release: miRdetect Receives Seed Financing – Consortium Invests Seven-Digit Amount in Serum Marker for Testicular Cancer Detection". 2019-05-02
Bruker Corporation. (5/2/19). "Press Release: Bruker Reports First Quarter 2019 Financial Results". Billerica, MA. 2019-05-02
Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg. 2019-05-02
Medigene AG. (5/2/19). "Press Release: Medigene Presented Data on Favorable Safety Pattern of PRAME-specific TCR on Neuronal Cells at 2019 ASGCT Meeting". Martinsried. 2019-05-02
Genedata AG. (5/2/19). "Press Release: Out-of-the-Box Integration of Genedata Bioprocess with MODDE Streamlines Bioprocess Development DOE". Basel. 2019-05-02
Numab Therapeutics AG. (5/2/19). "Press Release: CStone and Numab Announce Exclusive Regional Licensing Agreement for ND021, a Multi-functional Drug Candidate and Potential Next-generation Immunotherapy". Suzhou & Pfäffikon. 2019-05-02
Stilla Technologies SAS. (5/2/19). "Press Release: Renowned Digital PCR Experts at Ghent University Join Hands with Stilla Technologies to Expand the Frontiers of Crystal dPCR Using the Naica System". Ghent & Villejuif. 2019-05-02
Mission Therapeutics Ltd.. (5/1/19). "Press Release: Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors". Cambridge. 2019-05-01
Enzyre B.V.. (4/30/19). "Press Release: Enzyre Appoints Dirk Pollet as Chief Executive Officer. Awarded €2M Grant and Completes Seed Financing". Nijmegen. 2019-04-30
Alentis Therapeutics AG. (4/30/19). "Press Release: Alentis Therapeutics Launches, Raising CHF 12.5m in a Series A to Develop Novel Therapeutics in Advanced Liver Disease and Cancer". Basel. 2019-04-30
SGS S.A.. (4/30/19). "Press Release: SGS Implements Veeva Vault Clinical Trial Management System across its Global Network". 2019-04-30
Congenica Ltd.. (4/30/19). "Press Release: Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round". Cambridge. 2019-04-30
Codexis, Inc.. (4/30/19). "Press Release: Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of Tasteva M Stevia Sweetener". Redwood City, CA. 2019-04-30
Vividion Therapeutics, Inc.. (4/30/19). "Press Release: Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing". San Diego, CA. 2019-04-30
Charles River Laboratories International, Inc.. (4/29/19). "Press Release: Charles River Laboratories Completes the Acquisition of Citoxlab". Wilmington, MA. 2019-04-29
Canopy Biosciences, LLC. (4/29/19). "Press Release: Canopy Biosciences Acquires Zellkraftwerk GmbH". St. Louis, MO. 2019-04-29
Iktos. (4/29/19). "Press Release: Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery". Paris. 2019-04-29
CRISPR Therapeutics AG. (4/29/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results". Zug & Cambridge, MA. 2019-04-29
Uniqure N.V.. (4/29/19). "Press Release: Uniqure Announces First Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-04-29
Immunic, Inc.. (4/29/19). "Press Release: Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer". San Diego, CA. 2019-04-29
Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. 2019-04-27
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. 2019-04-26
Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.. 2019-04-26
Merck KGaA. (4/26/19). "Press Release: Wolfgang Büchele Re-elected Supervisory Board Chairman of Merck. Michael Fletterich Confirmed as Vice Chairman". Frankfurt a. M.. 2019-04-26
Sanofi S.A.. (4/26/19). "Press Release: Sanofi Delivers Strong Q1 2019 Business EPS Growth of 9.4% at CER". Paris. 2019-04-26
Biocartis Group N.V.. (4/25/19). "Press Release: Biocartis Q1 2019 Business Update". Mechelen. 2019-04-25
Eppendorf AG. (4/25/19). "Press Release: Eppendorf with Worldwide Setting Program. Around 250 Vacancies at All Locations by the End of 2019 – More than 100 New Jobs Planned". Hamburg. 2019-04-25
MeiraGTx Holdings plc. (4/25/19). "Press Release: MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019". London & New York, NY. 2019-04-25
Hookipa Pharma Inc.. (4/25/19). "Press Release: Hookipa Appoints David R. Kaufman to its Board of Directors". New York, NY & Vienna. 2019-04-25
Galapagos N.V.. (4/25/19). "Press Release: Galapagos Reports on Historic First Quarter 2019". Mechelen. 2019-04-25
PerkinElmer, Inc.. (4/25/19). "Press Release: PerkinElmer Announces Financial Results for the First Quarter of 2019". Waltham, MA. 2019-04-25
Genedata AG. (4/25/19). "Press Release: Genedata Wins 2019 Bio-IT World Best of Show Award for Deep Learning-Based Genedata Imagence". Basel. 2019-04-25
Labster ApS. (4/25/19). "Press Release: Labster Secures $21MM In Series B To Massively Expand Virtual Lab Catalog And Scale U.S. Operations". Boston, MA. 2019-04-25
next pagenext page 1 2 3 ... 63 64 65 ... 68 69 70  next pagenext page



Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x300px

» top